CSB Bank Limited has approved the grant of 1,33,831 stock options to its whole-time directors under the CSB Employee Stock Option Scheme (ESOP) 2019. The options, exercisable at ₹388.70 per share, will vest over a four-year period starting December 2026. Continuing employees will have a three-year exercise window from the vesting date.
Stock Option Grant Details
The stock options granted can be converted into an equal number of equity shares with a face value of ₹10 each, fully paid-up. The grant is intended to align the interests of the bank’s leadership with shareholder value creation and long-term performance.
| Parameter | Details |
| Total Options Granted | 1,33,831 |
| Exercise Price | ₹388.70 per share |
| Face Value | ₹10.00 per share |
| Vesting Period | Four years starting December 2026 |
| Exercise Period | Up to three years from vesting for continuing employees |
Vesting and Exercise
The options will vest over four years, beginning December 2026. The exercise period for employees who remain with the bank is within three years from the vesting date. In cases where employees separate from the organization, the exercise period will follow the specific provisions outlined in the ESOP 2019 scheme.
Corporate Governance and Disclosure
The grant has been approved by the bank’s board committee and disclosed in accordance with applicable regulatory requirements. The announcement has also been made publicly available on the bank’s website at www.csb.co.in, reflecting the bank’s commitment to transparency and corporate governance.
Summary:
CSB Bank has granted 1.34 lakh stock options to its whole-time directors under ESOP 2019, exercisable at ₹388.70 per share. The options will vest over four years starting December 2026, with a three-year exercise period for continuing employees. The grant aligns leadership incentives with long-term shareholder value and has been disclosed in compliance with regulatory requirements.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.